Qualifiers hierarchy
analysis Q05
blood Q05.010
cerebrospinal fluid Q05.020
isolation & purification Q05.030
urine Q05.040
blood supply Q10.010
cytology Q10.020
ultrastructure Q10.020.020
embryology Q10.030
abnormalities Q10.030.010
innervation Q10.040
pathology Q10.050
chemistry Q15
agonists Q15.010
analogs & derivatives Q15.020
antagonists & inhibitors Q15.030
chemical synthesis Q15.040
classification Q17
diagnosis Q20
diagnostic imaging Q20.010
drug effects Q22
education Q25
ethics Q30
etiology Q35
chemically induced Q35.010
complications Q35.020
secondary Q35.020.010
congenital Q35.030
embryology Q35.040
genetics Q35.050
immunology Q35.060
microbiology Q35.070
virology Q35.070.010
parasitology Q35.080
transmission Q35.090
history Q36
injuries Q37
instrumentation Q38
methods Q39
organization & administration Q40
economics Q40.010
legislation & jurisprudence Q40.020
standards Q40.040
supply & distribution Q40.050
trends Q40.060
pathogenicity Q42
pharmacology Q45
administration & dosage Q45.010
adverse effects Q45.020
poisoning Q45.020.010
toxicity Q45.020.020
agonists Q45.030
antagonists & inhibitors Q45.040
pharmacokinetics Q45.070
physiology Q50
genetics Q50.010
growth & development Q50.020
immunology Q50.030
metabolism Q50.040
biosynthesis Q50.040.010
blood Q50.040.020
cerebrospinal fluid Q50.040.030
deficiency Q50.040.040
enzymology Q50.040.050
pharmacokinetics Q50.040.060
urine Q50.040.070
physiopathology Q50.050
policies Q51
psychology Q52
statistics & numerical data Q55
epidemiology Q55.010
ethnology Q55.010.010
mortality Q55.010.020
supply & distribution Q55.020
therapeutic use Q60
administration & dosage Q60.010
adverse effects Q60.020
poisoning Q60.040
therapy Q65
diet therapy Q65.010
drug therapy Q65.020
nursing Q65.030
prevention & control Q65.040
radiotherapy Q65.050
rehabilitation Q65.060
surgery Q65.070
transplantation Q65.070.010
veterinary Q70
Updated: March, 2024
